Stock Traders Purchase Large Volume of Vitamin Shoppe Call Options (VSI)
Vitamin Shoppe Inc (NYSE:VSI) was the recipient of unusually large options trading on Monday. Stock traders bought 5,804 call options on the stock. This is an increase of 6,810% compared to the average volume of 84 call options.
Vitamin Shoppe (NYSE VSI) opened at $4.90 on Friday. Vitamin Shoppe has a 52-week low of $2.95 and a 52-week high of $23.85. The stock has a market capitalization of $117.49, a P/E ratio of -0.46 and a beta of 0.68. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.07 and a quick ratio of 0.32.
Vitamin Shoppe (NYSE:VSI) last announced its earnings results on Wednesday, November 8th. The specialty retailer reported ($0.03) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.17 by ($0.20). Vitamin Shoppe had a negative net margin of 29.89% and a negative return on equity of 136.50%. The business had revenue of $288.20 million during the quarter, compared to analyst estimates of $297.61 million. During the same period in the previous year, the company earned $0.50 earnings per share. The business’s revenue for the quarter was down 8.5% on a year-over-year basis. equities research analysts anticipate that Vitamin Shoppe will post 0.34 earnings per share for the current year.
In related news, major shareholder Vintage Capital Management Llc purchased 234,343 shares of Vitamin Shoppe stock in a transaction that occurred on Saturday, December 29th. The shares were purchased at an average cost of $4.36 per share, with a total value of $1,021,735.48. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders have purchased a total of 694,839 shares of company stock worth $3,214,809 over the last three months. 1.07% of the stock is currently owned by corporate insiders.
Several institutional investors and hedge funds have recently made changes to their positions in the business. Arizona State Retirement System raised its position in shares of Vitamin Shoppe by 0.8% in the 2nd quarter. Arizona State Retirement System now owns 12,460 shares of the specialty retailer’s stock valued at $145,000 after purchasing an additional 100 shares in the last quarter. BNP Paribas Arbitrage SA raised its position in shares of Vitamin Shoppe by 2.1% in the 2nd quarter. BNP Paribas Arbitrage SA now owns 9,242 shares of the specialty retailer’s stock valued at $108,000 after purchasing an additional 192 shares in the last quarter. Martingale Asset Management L P raised its position in shares of Vitamin Shoppe by 4.7% in the 2nd quarter. Martingale Asset Management L P now owns 27,008 shares of the specialty retailer’s stock valued at $315,000 after purchasing an additional 1,208 shares in the last quarter. Voya Investment Management LLC raised its position in shares of Vitamin Shoppe by 7.5% during the 2nd quarter. Voya Investment Management LLC now owns 34,810 shares of the specialty retailer’s stock valued at $406,000 after acquiring an additional 2,414 shares in the last quarter. Finally, Legal & General Group Plc raised its position in shares of Vitamin Shoppe by 9.3% during the 2nd quarter. Legal & General Group Plc now owns 44,555 shares of the specialty retailer’s stock valued at $518,000 after acquiring an additional 3,789 shares in the last quarter. 90.35% of the stock is currently owned by institutional investors.
Several research firms recently commented on VSI. ValuEngine lowered Vitamin Shoppe from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. Barclays cut their target price on Vitamin Shoppe from $6.00 to $3.00 and set an “equal weight” rating on the stock in a research report on Thursday, November 9th. Morgan Stanley cut their target price on Vitamin Shoppe from $7.50 to $4.00 and set an “equal weight” rating on the stock in a research report on Thursday, November 9th. Finally, Zacks Investment Research lowered Vitamin Shoppe from a “hold” rating to a “sell” rating in a research report on Tuesday, November 7th. Four equities research analysts have rated the stock with a sell rating and five have assigned a hold rating to the company’s stock. Vitamin Shoppe presently has a consensus rating of “Hold” and a consensus target price of $5.00.
Vitamin Shoppe Company Profile
Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.
Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with Analyst Ratings Network's FREE daily email newsletter.